We present a 44 year-old female with Angiotensin Converting Enzyme inhibitor-induced visceral angioedema. The patient presented with a short history of diarrhea. Her symptoms resolved with the elimination of lisinoprol. Her Computed tomography finding were reversed too.
Introduction
Angioedema is reported to be associated with a variety of causes including acquired C1 esterase deficiency, hereditary angioedema (HAE), and drugs. It is a rare side effect of Angiotensin ACE inhibitors. Angioedema, usually manifest as well-demarcated swelling of the tongue, lips, and other parts of the face but sometimes, patients present with lifethreatening peripheral angioedema. Visceral angioedema is a rarely reported side effect of ACE inhibitors and this condition can mimic an acute abdomen. Little is known about this condition, and unless the clinical suspicion is strong, patients may undergo unnecessary and invasive work-up. We present a case of ACE inhibitor-induced visceral angioedema and discuss the pertinent findings on computed tomography (CT) scan.
Case report
A 44 year-old woman presented to the emergency room with a 24-hour history of diarrhea and vomiting. She had no fever, stridor or facial swelling. She had no history of recent travel. Her past medical history included irritable bowel syndrome (IBS), hypertension and hyperlipidemia. She was recently started on Lisinopril, 5 mg once daily and had been taking Rosuvastain for the past one year for hyperlipidemia , She had no known drug allergies. On examination she had diffuse abdominal tenderness but no signs of peritonitis. The bowel sounds were present. She was afebrile and her blood pressure was 140/70 mmHg. Laboratory analysis was notable only for mild leukocytosis (17,100/mm3). Stool studies for fecal leukocytes, bacterial cultures, C. difficle toxin, and ova and parasites were negative. The serum C1 esterase level was within normal range. Initial plain film radiography of her abdomen was unremarkable. The patient underwent computed tomography of her abdomen and pelvis after the administration of oral and intravenous contrast media. This demonstrated a moderate amount of ascites within the abdomen and marked mucosal and submucosal edema in the ileum (Figs. 1 and 2). No free air or lymphadenopathy was identified and other organs appeared normal. The initial suspicion was of bowel wall thickening secondary to an infectious etiology but the pertinent work-up was reported negative. An ultrasoundguided paracentesis was performed on the day of admission, and the infection was ruled out. (Tables 1 & 2) . Patient was started on Lisinopril a week prior to admission for newly diagnosed hypertension. Lisinopril was stopped and her symptoms resolved, but recurred back when it was reintroduced. The ileal mucosal edema was presumed to be secondary to Lisinopril induced angioedema. The biopsies of ileum were normal and ruled out infection. The Lisinopril was stopped and her symptoms resolved. Repeat CT of the abdomen 24 hours later showed complete resolution of the bowel wall edema and ascites.
Discussion
Gastrointestinal complaints may be the presenting feature of patients with visceral angioedema. This condition can be idiopathic but can occur secondary to certain drugs, lymphoproliferative disorders(1), neoplasms (2), and autoimmune disorders (3). Hereditary forms have also been described. ACE-inhibitor-induced angioedema may mimic acquired angioedema and HAE syndrome, and presents with peripheral and/or visceral edema (4). Peripheral angioedema is a rare side effect of ACE inhibitors and occurs in less than 0.2% of patients (5, 6) . Slater et al reported the incidence of angioedema to be one case per 1000 patients treated (0.1%). ACE inhibitor induced visceral angioedema is a poorly understood and a rare side effect of this class of drugs. To our knowledge, only 20 cases have been reported. Visceral angioedema is a non-inflammatory disease characterized by increased capillary permeability with extravasations of intravascular fluid with resultant mucosal edema of the intestine. The symptoms can mimic an acute abdomen with patients presenting with abdominal pain, vomiting and watery diarrhea (Table 3 ) (7) (8) (9) (10) (11) (12) (13) . The most common CT findings are circumferential small bowel wall thickening and mucosal enhancement with prominence of the mesenteric vessels. Previously reported cases are due to Lisinopril (7-10), Enalopril (11, 12) and Captopril (13) ( Table 3 ). This is the first case of lisinopril-associated visceral angioedema. Interestingly, all reported cases have occurred in women in their fifth decade of life. The onset of symptoms varied from one day to 9 weeks after initiation of the drug. The episodes seemed to resolve within 24-48 hours after discontinuation of the offending drug. Other intra-abdominal processes such as ischemia, infections, inflammatory bowel disease, vasculitis, and neoplasms may mimic ACE-inhibitor-induced angioedema. We suspect the resolution of ascites was partially due to paracentesis and discontinuing Lisinopril. Ascites secondary to these other conditions is not expected to resolve without any intervention. Our patient presented with leukocytosis that we think was due to stress and dehydration, and it resolved the next day after discontinuation of Lisinopril. We decided not to resume Lisinopril due to the fear of potentially life threatening angioedema. She has done well without any recurrence of symptoms for one year. Clinicians should strongly consider visceral angioedema in patients with unexplained abdominal pain and taking ACE inhibitors. Clinician should consider a temporal relation between the initiation of this medication and acute abdomen. The pathogenesis of ACE-inhibitor induced visceral angioedema is not well understood. Some mechanisms probably involve antibody-antigen interactions, bradykinin, and histamine (5). Patients with a history of idiopathic angioedema (14) and C1 esterase inhibitor may be at a higher risk for ACEinhibitor-induced angioedema (25). A careful history is mandatory in making this diagnosis and thus avoiding unnecessary testing and surgery.
